The Different Expression of TRPM7 and MagT1 Impacts on the Proliferation of Colon Carcinoma Cells Sensitive or Resistant to Doxorubicin

Scientific Reports - United Kingdom
doi 10.1038/srep40538
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression

PLoS ONE
Multidisciplinary
2014English

Overexpression of Gelsolin Reduces the Proliferation and Invasion of Colon Carcinoma Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Growth-Inhibitory Effects of a Mineralized Extract From the Red Marine Algae, Lithothamnion Calcareum, on Ca2+-Sensitive and Ca2+-Resistant Human Colon Carcinoma Cells

Cancer Letters
Cancer ResearchOncology
2009English

Isolation and Characterization of a Human Colon Adenocarcinoma Cell Line Resistant to Doxorubicin

British Journal of Cancer
Cancer ResearchOncology
1986English

Antisense Oligonucleotides Against microRNA-21 Reduced the Proliferation and Migration of Human Colon Carcinoma Cells

Cancer Cell International
Cancer ResearchOncologyGenetics
2015English

SOX13 Dependent PAX8 Expression Promotes the Proliferation of Gastric Carcinoma Cells

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2019English

Characterization of a Clonal Human Colon Adenocarcinoma Line Intrinsically Resistant to Doxorubicin

British Journal of Cancer
Cancer ResearchOncology
1997English

Patterns of Gene Expression in Mammary Cells Following Carcinogen Exposure of Strains of Rat Sensitive or Resistant to Carcinogenesis

Nature Genetics
Genetics
2001English

Expression of EZH2 in Endometrial Carcinoma and Its Effects on Proliferation and Invasion of Endometrial Carcinoma Cells

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy